All candidates must be US citizens. Residency applications should be submitted through PhORCAS and are due no later than December 30, 2017. Candidates will be notified of the offer for an onsite interview by the middle of February, 2018. Application requirements are the same for the Acute Care (NMN143813) and the Ambulatory Care (NMN 143821) tracks. Please click here to view our updated information on applying to our program.
Susan Miller, PharmD, MBA, BCPS, CDE, FCCP
Pharmacy Residency Director
Director of Pharmacotherapy Education